MyongHak Ri

561 total citations
12 papers, 447 citations indexed

About

MyongHak Ri is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, MyongHak Ri has authored 12 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in MyongHak Ri's work include Ginseng Biological Effects and Applications (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). MyongHak Ri is often cited by papers focused on Ginseng Biological Effects and Applications (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). MyongHak Ri collaborates with scholars based in China and North Korea. MyongHak Ri's co-authors include Xuejun Jin, Juan Ma, Yue Xing, Ming Yue Li, Hong Xiang Zuo, Cheng Hua Jin, Lian Xun Piao, Zhi Hong Zhang, Jing Ying Wang and Guang Xu and has published in prestigious journals such as Journal of Ethnopharmacology, Pharmacological Research and Toxicology Letters.

In The Last Decade

MyongHak Ri

12 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
MyongHak Ri China	11	230	108	89	77	75	12	447
Xuan‐Run Wang Macao	9	284 1.2×	99 0.9×	114 1.3×	85 1.1×	41 0.5×	12	551
Jing Ying Wang China	14	325 1.4×	157 1.5×	134 1.5×	94 1.2×	73 1.0×	19	612
Shreya Kar Singapore	6	290 1.3×	138 1.3×	101 1.1×	98 1.3×	37 0.5×	8	500
Guoguo Jin China	14	350 1.5×	142 1.3×	131 1.5×	74 1.0×	31 0.4×	25	643
Seung Hwa Son South Korea	10	254 1.1×	105 1.0×	73 0.8×	74 1.0×	123 1.6×	14	474
Hongsheng Lin China	13	337 1.5×	147 1.4×	79 0.9×	65 0.8×	112 1.5×	26	697
Weili Min China	17	299 1.3×	132 1.2×	110 1.2×	45 0.6×	37 0.5×	26	591
Magdalena Dmoszyńska‐Graniczka Poland	14	329 1.4×	87 0.8×	61 0.7×	39 0.5×	100 1.3×	25	551
Man Sub Kim South Korea	15	240 1.0×	199 1.8×	73 0.8×	159 2.1×	93 1.2×	24	584
Chunpu Zou China	12	258 1.1×	86 0.8×	80 0.9×	80 1.0×	33 0.4×	24	458

Countries citing papers authored by MyongHak Ri

Since Specialization

Citations

This map shows the geographic impact of MyongHak Ri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MyongHak Ri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MyongHak Ri more than expected).

Fields of papers citing papers by MyongHak Ri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MyongHak Ri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MyongHak Ri. The network helps show where MyongHak Ri may publish in the future.

Co-authorship network of co-authors of MyongHak Ri

This figure shows the co-authorship network connecting the top 25 collaborators of MyongHak Ri. A scholar is included among the top collaborators of MyongHak Ri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MyongHak Ri. MyongHak Ri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ri, MyongHak, Yue Xing, Hong Xiang Zuo, et al.. (2023). Regulatory mechanisms of natural compounds from traditional Chinese herbal medicines on the microglial response in ischemic stroke. Phytomedicine. 116. 154889–154889. 20 indexed citations

Ri, MyongHak, Ming Yue Li, Yue Xing, et al.. (2023). Narirutin exerts anti‐inflammatory activity by inhibiting NLRP3 inflammasome activation in macrophages. Phytotherapy Research. 37(4). 1293–1308. 14 indexed citations

Ri, MyongHak, Juan Ma, & Xuejun Jin. (2021). Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. Journal of Ethnopharmacology. 281. 114370–114370. 31 indexed citations

Xing, Yue, Mingyue Li, Zhihong Zhang, et al.. (2021). Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-κB and Ras/Raf/MEK pathways. Journal of Ethnopharmacology. 273. 113989–113989. 61 indexed citations

Wang, Jing Ying, Ming Yue Li, Zhi Hong Zhang, et al.. (2021). Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation. The Journal of Nutritional Biochemistry. 100. 108899–108899. 46 indexed citations

Sun, Tong, Ming Yue Li, Zhi Hong Zhang, et al.. (2021). Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD‐L1 expression and enhancing T‐lymphocyte tumor‐killing activity. Phytotherapy Research. 35(7). 3916–3935. 37 indexed citations

Zhong, Yi, Zhi Hong Zhang, Jing Ying Wang, et al.. (2021). Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation. Toxicology Letters. 356. 75–88. 10 indexed citations

Yang, Ao, Ming Yue Li, Zhi Hong Zhang, et al.. (2020). Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity. Journal of Ethnopharmacology. 273. 113598–113598. 42 indexed citations

Zuo, Hong Xiang, Yong Jun Jin, Zhe Wang, et al.. (2020). Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer. Journal of Ethnopharmacology. 257. 112835–112835. 59 indexed citations

10.

Wang, Zhe, Ming Yue Li, Zhi Hong Zhang, et al.. (2020). Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells. Pharmacological Research. 155. 104727–104727. 85 indexed citations

11.

Zhang, Zhi Hong, Ming Yue Li, Jing Ying Wang, et al.. (2020). Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer. Phytomedicine. 81. 153425–153425. 28 indexed citations

12.

Guo, Qing, Zhao‐Bo Luo, Junxia Wang, et al.. (2019). Baicalin improves the in vitro developmental capacity of pig embryos by inhibiting apoptosis, regulating mitochondrial activity and activating sonic hedgehog signaling. Molecular Human Reproduction. 25(9). 538–549. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact